Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001683168-21-000788
Filing Date
2021-03-05
Accepted
2021-03-05 13:30:27
Documents
1
Group Members
LVP GP III, LLCLVP III ASSOCIATES, L.P.LVP III PARTNERS, L.P.LVP LIFE SCIENCE VENTURES III, L.P.LVPMC, LLCPATRICK F. LATTERELL

Document Format Files

Seq Description Document Type Size
1 FORM SC 13G AMENDMENT 1 lvp_sc13ga.htm SC 13G/A 93732
  Complete submission text file 0001683168-21-000788.txt   95767
Mailing Address 2533 S COAST HWY 101 SUITE 210 CARDIFF CA 92007
Business Address 2533 S COAST HWY 101 SUITE 210 CARDIFF CA 92007 858-400-8470
Viracta Therapeutics, Inc. (Subject) CIK: 0001061027 (see all company filings)

EIN.: 943295878 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-81034 | Film No.: 21717718
SIC: 2834 Pharmaceutical Preparations

Mailing Address 455 MARKET ST., SUITE 2220 SAN FRANCISCO CA 94105-2446
Business Address 455 MARKET ST., SUITE 2220 SAN FRANCISCO CA 94105-2446 415-399-9880
LVP LIFE SCIENCE VENTURES III L.P. (Filed by) CIK: 0001332654 (see all company filings)

EIN.: 203061469 | Fiscal Year End: 1231
Type: SC 13G/A